PRINTER'S NO. 1272
No. 169 Session of 2005
INTRODUCED BY LEACH, BAKER, BALDWIN, BEBKO-JONES, BELARDI,
CALTAGIRONE, CAWLEY, CORRIGAN, CRAHALLA, CRUZ, CURRY, DALEY,
DeWEESE, DiGIROLAMO, DONATUCCI, J. EVANS, FAIRCHILD, FORCIER,
FRANKEL, FREEMAN, GEIST, GEORGE, GERBER, GINGRICH, GOODMAN,
GRUCELA, HARHAI, HENNESSEY, HERMAN, HERSHEY, HESS, W. KELLER,
KENNEY, KIRKLAND, LEDERER, MAJOR, MARKOSEK, McGILL,
McILHATTAN, MUSTIO, PALLONE, PAYNE, READSHAW, ROBERTS, ROSS,
RUBLEY, SAINATO, SCHRODER, B. SMITH, TANGRETTI, TIGUE, WALKO,
GILLESPIE AND FABRIZIO, MARCH 29, 2005
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
MARCH 29, 2005
A RESOLUTION
1 Designating the week of May 8 through 14, 2005, as
2 "Mitochondrial Disease Awareness Week" in Pennsylvania.
3 WHEREAS, Mitochondrial disease comprises a panoply of
4 progressive, neurodegenerative syndromes affecting multiple
5 organ systems and causing mild to severe disabling neurological
6 complications; and
7 WHEREAS, Research has found that 1 in 2,000 people are
8 affected by a mitochondrial disease; and
9 WHEREAS, Research suggests that genetic defects in the
10 mitochondria may be linked to many chronic diseases associated
11 with age-related degeneration such as cancer, Alzheimer's
12 disease, Parkinson's disease and heart disease; and
13 WHEREAS, Mitochondrial disease can affect any person, any
14 organ, at any age, and at present there is no cure or effective
1 therapy for mitochondrial disease; and
2 WHEREAS, Organizations such as the United Mitochondrial
3 Disease Foundation provide much-needed support for families
4 coping with mitochondrial disease, encourage innovative research
5 of mitochondrial disease on several levels and sponsor more than
6 30 chapters and support groups throughout the United States;
7 therefore be it
8 RESOLVED, That the House of Representatives designate the
9 week of May 8 through 14, 2005, as "Mitochondrial Disease
10 Awareness Week" in Pennsylvania and urge all citizens of this
11 Commonwealth to become better informed about mitochondrial
12 disease and its impact.
A20L82SFL/20050H0169R1272 - 2 -